Scientists Solve 175-Year Anesthesia Mystery

For nearly two centuries, doctors have been putting patients safely to sleep for surgery without truly knowing how anesthesia works at the molecular level.

That mystery just got solved. Researchers at Weill Cornell Medicine and Birkbeck, University of London, have captured the first detailed images of exactly where and how anesthetic drugs bind to cells in the nervous system.

The team discovered that sevoflurane, a commonly used anesthetic, tucks into a tiny pocket on sodium ion channels. These channels act like gatekeepers for electrical signals between brain cells. When the anesthetic settles into this pocket, it locks the channels in an inactive state, preventing neurons from communicating and producing the unconsciousness needed for surgery.

"Sodium channels are critical for communication between neurons in the brain, and anesthesia breaks down that communication," said Dr. Hugh Hemmings, who co-led the research at Weill Cornell Medicine.

The discovery required some creative problem solving. Human sodium channels are too large and complex to study in such detail, so the researchers turned to a marine bacterium that uses similar channels to swim toward food and oxygen. Despite being structurally simpler, these bacterial channels respond to anesthetics the same way ours do.

Using high-resolution X-ray crystallography, the team captured detailed snapshots of the drug locked onto the channel. When they changed just one amino acid in the binding pocket, sevoflurane could no longer attach and lost its ability to keep the channel inactive.

Why This Inspires

This breakthrough represents hope for the 300 million people who undergo surgery with general anesthesia each year. Understanding exactly how these drugs work opens the door to designing anesthetics that are more targeted and effective, with fewer side effects like post-operative confusion or nausea.

The research also helps explain why some people react differently to anesthesia. Dr. Hemmings noted that studying natural variations in these binding sites could reveal why certain patients need more or less medication, leading to more personalized and safer care.

"The insights we gain from this study may enable us to design safer, more selective anesthetics," said Dr. Karl Herold, co-first author of the study published in Nature Communications.

The team is now working to translate their findings from bacterial channels to the human system. For anesthesiologists like Dr. Hemmings, who is also anesthesiologist-in-chief at NewYork-Presbyterian/Weill Cornell Medical Center, understanding these mechanisms isn't just academic curiosity.

"As anesthesiologists, it's our responsibility to understand how these drugs work, so we can resolve issues when people don't react well to anesthesia," he explained.

After 175 years of safe but mysterious use, anesthesia is finally revealing its secrets, and the future of surgical care looks brighter for it.